Market Overview

Global +$5Bn Endotherapy Devices Market to 2024 - Opportunity Analysis and Industry Forecast -


The "Endotherapy
Devices Market by Product, ERCP Devices & Accessories, and Other
Endotherapy Devices & Accessories, Application, and End Users -
Opportunity Analysis and Industry Forecast, 2017-2024"
has been added to's offering.

According to the report, the global endotherapy devices market accounted
for $3,369 million in 2017, and is expected to reach $5,015 million by
2024, registering a CAGR of 5.9% from 2018 to 2024. North America is the
highest contributor in the global endotherapy devices market in 2017;
however, Asia-Pacific is expected to witness the highest growth rate
during the forecast period.

Increase in prevalence of diseases that require endotherapy devices as
well as technological advancements in endotherapy devices drives the
market growth. Furthermore, shorter recovery time, minimal postoperative
complications, and rise in patient preference for minimally invasive
surgeries are projected to supplement the market growth.

Moreover, unmet medical demands and lucrative opportunities in the
emerging and developing countries such as China and India offer
profitable opportunities for market expansion.

However, infections caused by few endotherapy, dearth of trained
physicians & endoscopists, and high costs associated with endotherapy
devices could hamper the market growth.

Segment Analysis

Among the products, GI devices & accessories segment is the dominant
segment contributing towards the growth of global endotherapy devices
market in 2017 owing to the increase in incidence of gastrointestinal
disorders and diseases requiring the use of GI endotherapy.

Hospitals are expected to maintain its lead in the overall end user of
the endotherapy devices market, due to the availability of diverse
endotherapy services and favorable reimbursement policies. Most
hospitals are well equipped with technologically advanced endoscopic
facilities in the developed economies.

The growth in demand for endoscopy devices in developed economies such
as North America and Europe have further boosted the market growth due
to the high prevalence rate of complex diseases such as cancer and rapid
increase in geriatric population. Although the endoscopic needs are also
largely felt in developing economies, low awareness, lack of skilled
professionals, and unmet medical needs at economical cost hamper the
market growth in these areas.

Competitive Landscape

The key players operating in the global endotherapy devices market
include Hoya Corporation, Olympus Corporation, Stryker Corporation,
Boston Scientific Corporation, Fujifilm Holdings Corporation, Conmed
Corporation Medtronic Plc., Karl Storz GmbH & Co. KG, Smith & Nephew,
Plc., and Johnson & Johnson.

Other prominent players in the value chain include B. Braun Melsungen
AG, Cook Medical, Siemens Healthcare, Steris Corporation, Frontier
Healthcare, and Advanced Sterilization Products Services Inc.

Key Findings

  • ERCP devices & accessories is projected to grow at the highest rate
    during the analysis period.
  • Japan dominated Asia-Pacific endotherapy devices market in 2017, and
    is projected to continue its dominance in future.
  • Guide wire is expected to grow highest globally during the forecast
  • Graspers is the largest contributor among the GI devices and
    consumables in 2017.
  • Distal end cap generated the highest revenue in 2017, and is expected
    to continue its dominance in future.
  • Gastrointestinal endoscopy application is growing at the fastest pace
    during 2018-2024.

Key Topics Covered

Chapter 1: Introduction

Chapter 2: Executive Summary

Chapter 3: Market Overview

Chapter 4: Global Endotherapy Devices Market, By Product

Chapter 5: Global Endotherapy Devices Market By Application

Chapter 6: Global Endotherapy Devices Market By End Users

Chapter 7: Endotherapy Devices Market, By Region

Chapter 8: Company Profiles

  • Boston Scientific Corporation
  • CONMED Corporation
  • FUJIFILM Holdings Corporation
  • HOYA Corporation
  • Johnson & Johnson (Ethicon, Inc.)
  • Medtronic Plc.
  • Olympus Corporation
  • Stryker Corporation
  • Smith & Nephew Plc.

For more information about this report visit

View Comments and Join the Discussion!